We are live on ! Find out more
Prudential Financial

Prudential Financial Portfolio holdings

AUM $81.2B
1-Year Est. Return 27.81%
This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+27.81%
3 Year Est. Return
+94.87%
5 Year Est. Return
+128.33%
10 Year Est. Return
+450.33%
AUM
$80.6B
AUM Growth
+$8.82B
Cap. Flow
+$2.64B
Cap. Flow %
3.28%
Top 10 Hldgs %
23.94%
Holding
2,752
New
170
Increased
968
Reduced
1,472
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 22.12%
2 Healthcare 11.53%
3 Financials 10.95%
4 Consumer Discretionary 10.22%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGEN
2601
Agenus
AGEN
$249M
$50K ﹤0.01%
785
-20
-2% -$1.58K
NEX
2602
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$48K ﹤0.01%
13,606
-1,060
-7% -$4.44K
ATRS
2603
DELISTED
Antares Pharma, Inc.
ATRS
$45K ﹤0.01%
12,645
-7,102
-36% -$24.8K
SAN icon
2604
Banco Santander
SAN
$194B
$44K ﹤0.01%
11,775
-42
-0.4% -$148
XXII
2605
22nd Century Group
XXII
$1.47M
0
MMAT
2606
DELISTED
Meta Materials Inc. Common Stock
MMAT
$35K ﹤0.01%
143
-28
-16% -$11.5K
IDEX
2607
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$32K ﹤0.01%
214
-9
-4% -$1.92K
RIGL icon
2608
Rigel Pharmaceuticals
RIGL
$680M
$30K ﹤0.01%
1,146
-105
-8% -$3.17K
DFTX
2609
Definium Therapeutics
DFTX
$5.73B
$28K ﹤0.01%
1,349
-168
-11% -$5.36K
GERN icon
2610
Geron
GERN
$911M
$26K ﹤0.01%
20,932
-1,720
-8% -$2.46K
LCTX icon
2611
Lineage Cell Therapeutics
LCTX
$257M
$26K ﹤0.01%
10,485
-815
-7% -$1.91K
VBIV
2612
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$25K ﹤0.01%
363
-43
-11% -$3.62K
VTGN icon
2613
VistaGen Therapeutics
VTGN
$9.29M
$20K ﹤0.01%
336
-43
-11% -$2.8K
NAT icon
2614
Nordic American Tanker
NAT
$1.37B
$19K ﹤0.01%
11,115
-6,406
-37% -$13.8K
TOON icon
2615
Kartoon Studios
TOON
$34.3M
$19K ﹤0.01%
1,794
-196
-10% -$2.56K
TCRT icon
2616
Alaunos Therapeutics
TCRT
$4.74M
$17K ﹤0.01%
102
-9
-8% -$1.98K
ASXC
2617
DELISTED
Asensus Surgical, Inc.
ASXC
$16K ﹤0.01%
14,695
-1,555
-10% -$2.4K
NMTR
2618
DELISTED
9 Meters Biopharma
NMTR
$15K ﹤0.01%
761
-71
-9% -$1.59K
DRRX
2619
DELISTED
DURECT Corp
DRRX
$14K ﹤0.01%
1,476
-2,060
-58% -$22.8K
TXMD icon
2620
TherapeuticsMD
TXMD
$23.8M
$9K ﹤0.01%
479
-51
-10% -$1.53K
ATHX
2621
DELISTED
Athersys, Inc. Common Stock
ATHX
$9K ﹤0.01%
417
-47
-10% -$1.35K
AMPE
2622
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$8K ﹤0.01%
47
-5
-10% -$1.86K
IBIO icon
2623
iBio
IBIO
$71M
$7K ﹤0.01%
24
-3
-11% -$1.14K
TRVN
2624
DELISTED
Trevena, Inc.
TRVN
$7K ﹤0.01%
19
-33
-63% -$18.3K
EMWP
2625
DELISTED
Eros Media World PLC
EMWP
$4K ﹤0.01%
899
-111
-11% -$1.27K

Similar funds

Prudential Financial's Q4 2021 Portfolio in Review

As of Q4 2021, Prudential Financial held 2,752 positions worth $80.6B, up 12% from $71.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Prudential Financial deployed $2.64B of net new capital in Q4 2021, opening 170 new positions and adding to 968 existing holdings. Its largest new stake was iShares US Healthcare ETF: 3,386,510 shares worth $203M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $146M trimmed.

  • Prudential Financial's largest Q4 2021 buy was iShares US Healthcare ETF: 3,386,510 shares worth $203M.
  • Prudential Financial added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $1.11B increase.
  • Prudential Financial's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $146M.
  • Prudential Financial fully exited Extraction Oil & Gas, Inc. Common Stock in Q4 2021, selling an estimated $157M.
  • Prudential Financial's ten largest holdings make up 24% of its $80.6B portfolio in Q4 2021.
  • Prudential Financial opened 170 new positions and closed 126 in Q4 2021.
  • Prudential Financial's portfolio value rose 12% quarter-over-quarter to $80.6B.

Based on Prudential Financial's 13F filing for Q4 2021, filed 14 Feb 2022.